← Back
$INDV All transactions

Indivior Pharmaceuticals, Inc.

F

$ Value

$2.8M

Shares

87,597

Price

$32

Filed

Mar 5

Insider

Name

Preblick Ryan

Title

Chief Financial Officer

CIK

0002014866

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

230,343

Footnotes

In 2024, 204,904 shares vested in respect of performance stock units granted to the Reporting Person on March 3, 2021. These shares were subject to a further two-year holding period. On March 3, 2026, the holding period ended and 87,597 shares were withheld to satisfy tax withholding obligations. | Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 86,949 shares vested out of the 113,510 target amount. These shares will be released following a two-year holding period. | Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock.

Filing Info

Accession No.

0002014866-26-000006

Form Type

4

Issuer CIK

0001625297

Preblick Ryan's History

Date Ticker Type Value
2026-03-14 INDV M
2026-03-14 INDV F $88K
2026-03-14 INDV M
2026-03-03 INDV F $2.8M
2026-03-03 INDV M
2026-03-03 INDV M
2026-02-10 INDV A $0
2026-02-09 INDV A $0

Other Insiders at INDV (90d)

Insider Bought Sold Last
Kingsley Stuart A $30K 2026-03-06
Ryan Barbara $1K 2026-03-13
NINIVAGGI DANIEL A 2026-01-26
Ciaffoni Joseph
Chief Executive Officer
2026-02-10
Burris Jeffrey W
Chief Legal Officer
2026-03-03
Stejbach Mark 2026-01-26
Thompson Juliet 2026-01-26
Barry Patrick A
Chief Commercial Officer
2026-02-10
Wheadon David E. 2026-01-26
Anderson Woodrow D
Chief Accounting Officer
2026-03-03
Heidbreder Christian
Chief Scientific Officer
2026-03-03
Preblick Ryan
Chief Financial Officer
2026-03-14
Humphreys Keith 2026-01-26